A glimmer of hope may be on the horizon for a ruthless cancer that former Sen. Ben Sasse (R-Neb.) once called a “definite death sentence.” An experimental treatment from Revolution Medicines helped ...

The FDA’s approval of daraxonrasib marks a significant development in pancreatic cancer treatment, with clinical trial ...

The US Food and Drug Administration has just approved a new treatment for metastatic pancreatic cancer after a phase 3 trial ...

The drug, called Rasonque, is a once-daily pill for people with pancreatic cancer who've received prior treatment, or can't ...

Imagine if, before starting cancer care, doctors could rapidly identify the most effective chemotherapy, immunotherapy or combination to personalize treatment for a loved one's hard-to-treat ...

A pill that doubles life expectancy in patients with pancreatic cancer has been hailed as the biggest breakthrough for decades. Doctors are billing daraxonrasib as a “revolution” in cancer treatment, ...

Pancreatic cancer is one of the rarest cancers, but it's also among the deadliest, and oncologists and patients have been desperate for a better treatment. Though the five-year survival rate for all ...

Surprising’ numerical differences favoring chemoradiation on survival, but SBRT may offer a quality-of-life advantage.

Scientists have developed a blood test that can identify symptomless pancreatic cancer with 97 per cent accuracy, raising hopes that the deadly disease could be caught much earlier. Around 11,500 ...

Yet I kept dragging my feet, in part because it was less painful to ignore the danger. Over time I would put aside my reluctance, encouraged by my wife and something one of my brothers said shortly ...